Transcatheter Aortic Valve Replacement to UNload the Left

Recruiting

99 years or below

All

20 participants needed

1 Location

Brief description of study

Randomized (flip of the coin 50/50) study of heart failure (HF) patients with moderate aortic valve stenosis (narrowing) will be either treated with a transcatheter valve replacement (TAVR) or continue with medical management. Subjects will be followed for 2 years. We will collect information regarding death and major events such as stroke and also ask you about your quality of life and functional status.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: heart failure
Age: 99 years or below
Gender: All

Updated on 04 Aug 2024. Study ID: 827692

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure

Brief description of study

Eligibility of study

Find a site

Interested in the study